Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiation Therapy To Enhance CAR T Efficacy Early in Post-CAR T Cell Therapy Refractory Lymphoma: A Pilot Study

NCT04473937 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT04473937
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04473937 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiation Therapy To Enhance CAR T Efficacy Early in Post-CAR T Cell Therapy Refractory Lymphoma: A Pilot Study
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Terminated
Start date
January 5, 2021
Completion date
July 3, 2023
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematologic malignancy, refractory lymphoma